科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/27 | 3,607 | 3,621 | 3,586 | 3,586 | -9 | -0.3% | 222,500 |
| 2024/03/26 | 3,585 | 3,600 | 3,567 | 3,595 | +4 | +0.1% | 137,200 |
| 2024/03/25 | 3,590 | 3,606 | 3,560 | 3,591 | -13 | -0.4% | 176,900 |
| 2024/03/22 | 3,580 | 3,614 | 3,579 | 3,604 | +44 | +1.2% | 182,300 |
| 2024/03/21 | 3,558 | 3,571 | 3,542 | 3,560 | +9 | +0.3% | 131,100 |
| 2024/03/19 | 3,530 | 3,557 | 3,523 | 3,551 | +12 | +0.3% | 120,500 |
| 2024/03/18 | 3,530 | 3,545 | 3,527 | 3,539 | +15 | +0.4% | 95,000 |
| 2024/03/15 | 3,520 | 3,536 | 3,509 | 3,524 | -5 | -0.1% | 135,400 |
| 2024/03/14 | 3,538 | 3,538 | 3,515 | 3,529 | +8 | +0.2% | 85,000 |
| 2024/03/13 | 3,540 | 3,550 | 3,521 | 3,521 | -23 | -0.6% | 148,400 |
| 2024/03/12 | 3,535 | 3,546 | 3,495 | 3,544 | +5 | +0.1% | 161,000 |
| 2024/03/11 | 3,530 | 3,543 | 3,513 | 3,539 | +16 | +0.5% | 163,800 |
| 2024/03/08 | 3,530 | 3,567 | 3,520 | 3,523 | -55 | -1.5% | 230,000 |
| 2024/03/07 | 3,576 | 3,602 | 3,566 | 3,578 | +13 | +0.4% | 123,200 |
| 2024/03/06 | 3,549 | 3,583 | 3,549 | 3,565 | +11 | +0.3% | 112,300 |
| 2024/03/05 | 3,561 | 3,574 | 3,546 | 3,554 | -7 | -0.2% | 137,000 |
| 2024/03/04 | 3,533 | 3,572 | 3,518 | 3,561 | +28 | +0.8% | 118,800 |
| 2024/03/01 | 3,545 | 3,551 | 3,518 | 3,533 | -18 | -0.5% | 156,400 |
| 2024/02/29 | 3,557 | 3,574 | 3,531 | 3,551 | -8 | -0.2% | 164,000 |
| 2024/02/28 | 3,575 | 3,586 | 3,559 | 3,559 | -16 | -0.4% | 100,200 |
| 2024/02/27 | 3,553 | 3,580 | 3,548 | 3,575 | +23 | +0.6% | 99,800 |
| 2024/02/26 | 3,551 | 3,578 | 3,549 | 3,552 | +11 | +0.3% | 78,100 |
| 2024/02/22 | 3,541 | 3,549 | 3,517 | 3,541 | ±0 | ±0% | 109,400 |
| 2024/02/21 | 3,585 | 3,585 | 3,523 | 3,541 | -43 | -1.2% | 115,000 |
| 2024/02/20 | 3,587 | 3,592 | 3,572 | 3,584 | -4 | -0.1% | 88,300 |
| 2024/02/19 | 3,554 | 3,589 | 3,547 | 3,588 | +50 | +1.4% | 91,200 |
| 2024/02/16 | 3,526 | 3,550 | 3,522 | 3,538 | +33 | +0.9% | 105,600 |
| 2024/02/15 | 3,519 | 3,523 | 3,487 | 3,505 | -14 | -0.4% | 105,800 |
| 2024/02/14 | 3,543 | 3,550 | 3,494 | 3,519 | -24 | -0.7% | 82,000 |
| 2024/02/13 | 3,507 | 3,543 | 3,496 | 3,543 | +37 | +1.1% | 101,500 |
| 2024/02/09 | 3,480 | 3,513 | 3,457 | 3,506 | +9 | +0.3% | 144,300 |
| 2024/02/08 | 3,515 | 3,522 | 3,467 | 3,497 | -14 | -0.4% | 153,800 |
| 2024/02/07 | 3,547 | 3,571 | 3,498 | 3,511 | -19 | -0.5% | 122,400 |
| 2024/02/06 | 3,501 | 3,543 | 3,496 | 3,530 | +29 | +0.8% | 101,300 |
| 2024/02/05 | 3,494 | 3,519 | 3,490 | 3,501 | +7 | +0.2% | 80,200 |
| 2024/02/02 | 3,501 | 3,510 | 3,491 | 3,494 | -6 | -0.2% | 67,400 |
| 2024/02/01 | 3,475 | 3,513 | 3,471 | 3,500 | +10 | +0.3% | 92,000 |
| 2024/01/31 | 3,477 | 3,492 | 3,442 | 3,490 | -1 | ±0% | 106,000 |
| 2024/01/30 | 3,515 | 3,515 | 3,488 | 3,491 | ±0 | ±0% | 64,400 |
| 2024/01/29 | 3,492 | 3,515 | 3,489 | 3,491 | -1 | ±0% | 61,300 |
| 2024/01/26 | 3,495 | 3,509 | 3,483 | 3,492 | -5 | -0.1% | 90,300 |
| 2024/01/25 | 3,468 | 3,497 | 3,465 | 3,497 | +18 | +0.5% | 57,500 |
| 2024/01/24 | 3,488 | 3,496 | 3,465 | 3,479 | -14 | -0.4% | 66,300 |
| 2024/01/23 | 3,496 | 3,518 | 3,490 | 3,493 | +3 | +0.1% | 84,900 |
| 2024/01/22 | 3,467 | 3,495 | 3,467 | 3,490 | +31 | +0.9% | 52,000 |
| 2024/01/19 | 3,478 | 3,488 | 3,456 | 3,459 | -28 | -0.8% | 108,700 |
| 2024/01/18 | 3,490 | 3,496 | 3,481 | 3,487 | -11 | -0.3% | 63,400 |
| 2024/01/17 | 3,524 | 3,534 | 3,493 | 3,498 | -3 | -0.1% | 91,500 |
| 2024/01/16 | 3,510 | 3,526 | 3,493 | 3,501 | -6 | -0.2% | 90,400 |
| 2024/01/15 | 3,480 | 3,510 | 3,478 | 3,507 | +27 | +0.8% | 87,400 |
301～
350
件表示中 / 3723件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,000円 | -6.4% | -71.8% | 4.92% | 43.11倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 378,000円 | +21.7% | +999.9% | 0.00% | 15.84倍 | 5.24倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 299,900円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
